← All companies
BNGO
Bionano Genomics, Inc.
$1.12
+0.04 +4.21%
Key statistics
from XBRL data in SEC filingsMarket cap
$12.8M
Revenue (TTM)
$28.7M
Net income (TTM)
-$31.6M
EPS (TTM)
$-4.46
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$3.42M
Total assets
$64.8M
Gross margin
—
52-week range
$1.00 – $5.50
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 24, 2026
8-K
Director or officer change
Jun 5, 2026
8-K
Other events
May 28, 2026
8-K
Shareholder vote results
May 14, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Results of operations (earnings release)
May 13, 2026
8-K
Director or officer change; Other events
May 6, 2026
10-K
Fiscal year ended 2025-12-31
Mar 23, 2026
8-K
Results of operations (earnings release)
Mar 23, 2026
8-K
Results of operations (earnings release)
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
8-K
Entered a material agreement; Other events
Sep 18, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K/A
Shareholder vote results
Jun 18, 2025
8-K
Director or officer change; Shareholder vote results
Jun 13, 2025
10-Q
Quarter ended 2025-03-31
May 14, 2025
8-K
Results of operations (earnings release)
May 14, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Results of operations (earnings release)
Mar 31, 2025
8-K
Entered a material agreement
Feb 21, 2025
8-K
Terminated a material agreement
Feb 10, 2025
8-K
Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure
Jan 27, 2025
8-K
Shareholder vote results
Jan 16, 2025
8-K
Results of operations (earnings release)
Jan 13, 2025
8-K
Entered a material agreement; Regulation FD disclosure; Other events
Jan 6, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Jan 3, 2025
8-K
Shareholder vote results
Dec 2, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Results of operations (earnings release)
Nov 13, 2024
8-K
Entered a material agreement; Regulation FD disclosure; Other events
Oct 31, 2024
8-K
Results of operations (earnings release)
Oct 10, 2024
8-K
Exit or disposal costs; Director or officer change; Regulation FD disclosure
Sep 9, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Delisting notice or listing-rule failure
Jul 18, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events
Jul 8, 2024
8-K
Shareholder vote results
Jun 21, 2024
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events
May 28, 2024